Other cancer risks
Breast and ovarian cancer risks
Other cancer risks
Chemoprevention and breast cancer
Chemoprevention and ovarian cancer
Close surveillance for breast cancer
Primary
Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for
Ovarian Cancer Risk Reduction
Michael J. Callahan, Christopher P. Crum,
Fabiola Medeiros, David W. Kindelberger, Julia A. Elvin, Judy E. Garber,
Colleen M. Feltmate, Ross S. Berkowitz, Michael G. Muto. Journal
of Clinical Oncology. Volume 25, No. 25: p. 3985-3990, September 2007.
Intra-abdominal
carcinomatosis after prophylactic oophorectomy in women of hereditary breast
ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations
Murray
Joseph Casey, Carrie Synder, Chhanda Bewtra, Steven A. Narod, Patrice Watson
and Henry T. Lynch. Gynecologic Oncology. Volume 97, Issue 2 , p. 457-467,
May 2005.
BRCA
Mutations and risk of prostate cancer in Ashkenazi Jews
Tomas Kirchhoff,
Noah D. Kauff, Nandita Mitra, Kedoudja Nafa, Helen Huang, Crystal Palmer,
Tony Gulati, Eve Wadsworth, Sheri Donat, Mark E. Robson, Nathan A. Ellis
and Kenneth Offit. Clinical Cancer Research. Volume 10, p. 2918-2921, May
1, 2004.
BRCA
germline mutations in Jewish women with uterine serous papillary carcinoma
Ofer
Lavie, Gila Hornreich, Alon Ben-Arie, Gad Rennert, Yoram Cohen, Rehuven
Keidar, Shlomi Sagi, Efrat Levy Lahad, Ron Auslander and Uzi Beller. Gynecologic
Oncology, Volume 92, Number 2: p. 521-524, February 2004.
BRCA1
and BRCA2 founder mutations and the risk of colorectal cancer
Bethany
L. Niell, Gad Rennert, Joseph D. Bonner, Ronit Almog, Lynn P. Tomsho, and
Stephen B. Gruber. Journal of the National Cancer
Institute. Volume 96:
p, 15-21, January 2004.
Frequency
of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with
colorectal cancer
Tomas Kirchhoff, Jaya M. Satagopan, Noah D. Kauff,
Helen Huang, Prema Kolachana, Crystal Palmer, Hannah Rapaport, Khedoudja
Nafa, Nathan A. Ellis, Kenneth Offit. Journal
of the National Cancer Institute.
Volume 96: p, 68-70, January 2004.
Fallopian tube
and primary peritoneal carcinomas associated with BRCA mutations
Douglas
A. Levine, Peter A. Argenta, Cindy J. Yee, David S. Marshall, Narciso Olvera,
Faina Bogomolniy, Jamal A. Rahaman, Mark E. Robson, Kenneth Offit, Richard
R. Barakat, Robert A. Soslow, Jeff Boyd. Journal
of Clinical Oncology.
Volume 21, Issue 22: p. 4222-4227, November 2003.
BRCA1
and BRCA2 germline mutations in lymphoma patients
Yossepowitch O, Olvera
N, Satagopan JM, Huang H, Jhanwar S, Rapaport B, Boyd J, Offit K. Leukemia & Lymphoma.
Volume 44, Number 1: p. 127-31 January 2003. (Pubmed abstract)
Two
percent of men with early-onset prostate cancer harbor germline mutations
in the BRCA2 gene
Stephen M. Edwards, Zsofia Kote-Jarai, Julia Meitz,
Rifat Hamoudi, Questa Hope, Peter Osin, Rachel Jackson, Christine Southgate,
Rashmi Singh, Alison Falconer, David P. Dearnaley, Audrey Ardern-Jones,
Annette Murkin, Anna Dowe, Jo Kelly, Sue Williams, Richard Oram, Margaret
Stevens, Dawn M. Teare, Bruce A. J. Ponder, Simon A., Gayther, Doug F.
Easton, and Rosalind A. Eeles. American Journal
of Human Genetics. Volume
72: p. 1-12, January 2003.
BRCA2
gene mutations in families with aggregations of breast and stomach cancers
A
Jakubowska, K Nej, T Huzarski, R J Scott and J Lubiski. British
Journal of Cancer. Volume 87: p. 888-891 October 2002.
Cancer
risk estimates for BRCA1 mutation carriers identified in a risk evaluation
program
Marcia S. Brose, Timothy R. Rebbeck, Kathleen A. Calzone, Jill
E. Stopfer, Katherine L. Nathanson, Barbara L. Weber. Journal
of the National Cancer Institute. Volume 94, Number 18: p.1365-1372, September 18, 2002.
Cancer
incidence in BRCA1 mutation carriers
Deborah Thompson, Douglas F. Easton,
the Breast Cancer Linkage Consortium. Journal
of the National Cancer Institute.
Volume 94, Number. 18: p. 1358-1365, September 18, 2002.
Clinical characteristics
of individuals with germline mutations in BRCA1 and BRCA2: Analysis of
10,000 individuals
Thomas S. Frank, Amie M. Deffenbaugh, Julia E. Reid,
Mark Hulick, Brian E. Ward, Beth Lingenfelter, Kathi L. Gumpper, Thomas
Scholl, Sean V. Tavtigian, Dmitry R. Pruss, Gregory C. Critchfield. Journal
of Clinical Oncology. Volume 20, Issue 6: p. 1480-1490, March 2002.
Risk of endometrial carcinoma
associated with BRCA mutation
Douglas A. Levine M.D., Oscar Lin M.D.,
Richard R. Barakat M.D., Mark E. Robson M.D., Deborah McDermott M.S., Lesley
Cohen M.S., Jaya Satagopan Ph.D., Kenneth Offit M.D. and Jeff Boyd Ph.D.
Gynecologic Oncology. Volume 80, Number 3: p. 395-398, March 2001.
A genetic epidemiological
study of carcinoma of the fallopian tube
Samina Aziz, Graciela Kuperstein,
Barry Rosen, David Cole, Raluca Nedelcu, John McLaughlin and Steven A.
Narod. Gynecologic Oncology. Volume 80, Number 341: p. 341-345, March 2001.
Variation
in cancer risks, by mutation position, in BRCA2 mutation carriers
Deborah
Thompson and Douglas Easton, on behalf of the Breast Cancer Linkage Consortium.
American Journal of Human Genetics. Volume 68: p. 410-419, January 2001.
Cancer
risks in BRCA2 mutation carriers
The Breast Cancer Linkage Consortium.
Journal of the National Cancer Institute. Volume 91, Number 15: p 1310-1316,
August 4, 1999.